Elevated Cortisol Symptoms: What Could Be Causing Them?

Why Cortisol Rises and Why It Matters

Cortisol is a glucocorticoid hormone released by the adrenal glands under control of the hypothalamic-pituitary-adrenal (HPA) axis. The hypothalamus secretes corticotropin-releasing hormone (CRH), which stimulates pituitary adrenocorticotropic hormone (ACTH), which then drives adrenal cortisol output. Negative feedback normally keeps levels within a tight diurnal range, peaking around 6 to 8 AM and falling to a nadir near midnight 1. When any part of this loop is disrupted, cortisol stays elevated.

Sustained hypercortisolism damages nearly every organ system. Bone mineral density drops because cortisol suppresses osteoblast activity and increases resorption 2. Visceral adiposity expands due to cortisol-driven lipogenesis in central depots 3. Immune function shifts toward immunosuppression, raising infection risk 4. Cardiovascular risk climbs through hypertension, insulin resistance, and dyslipidemia. The clinical picture can look deceptively like common metabolic syndrome. That overlap is exactly why so many patients wait years before getting a proper workup.

Exogenous Glucocorticoids: The Most Frequent Culprit

The single most common reason for elevated cortisol symptoms is iatrogenic: prescription corticosteroids. Prednisone, dexamethasone, methylprednisolone, and inhaled fluticasone at high doses can all suppress the HPA axis and simultaneously flood tissues with exogenous glucocorticoid activity 5. Even topical and intra-articular steroid preparations produce systemic absorption sufficient to cause cushingoid features in susceptible patients 6.

A 2015 UK population-based study found that oral corticosteroid prescriptions were dispensed to approximately 1% of the adult population at any given time 5. Among those on chronic oral glucocorticoids (more than 3 months), iatrogenic Cushing features appeared in up to 70%. Dose and duration are the two biggest predictors. Any patient on the equivalent of 7.5 mg or more of prednisone daily for over 3 weeks should be monitored for adrenal suppression and cushingoid changes.

The fix sounds simple: taper the steroid. But abrupt withdrawal after prolonged use can trigger adrenal crisis because endogenous production has been suppressed. Gradual dose reduction under clinician supervision is the standard of care 7.

Cushing Syndrome: Endogenous Overproduction

When exogenous steroids are ruled out, the next consideration is endogenous Cushing syndrome. The Endocrine Society's 2008 clinical practice guideline (reaffirmed in subsequent reviews) recommends screening patients who have multiple progressive features: unexplained osteoporosis, central obesity with proximal myopathy, wide (greater than 1 cm) violaceous striae, facial plethora, or an adrenal incidentaloma 8.

Roughly 70% of endogenous cases are ACTH-dependent, caused by a pituitary corticotroph adenoma, which is the subtype specifically called Cushing disease 9. Another 10 to 15% are ectopic ACTH secretion from small-cell lung carcinoma, bronchial carcinoids, or pancreatic neuroendocrine tumors 10. The remaining 15 to 20% are ACTH-independent, driven by adrenal adenomas, carcinomas, or bilateral macronodular hyperplasia.

Distinguishing these subtypes matters enormously for treatment. Transsphenoidal surgery achieves initial remission in 65 to 90% of pituitary-driven cases at experienced centers 9. Ectopic sources require localization (often with gallium-68 DOTATATE PET/CT) and resection when possible. Adrenal tumors are managed with adrenalectomy.

Chronic Stress and HPA Axis Dysregulation

Not every patient with elevated cortisol has a tumor. Chronic psychological stress is the most widespread driver of sustained HPA axis activation. A 2017 study measuring hair cortisol concentrations (reflecting cumulative exposure over months) found that individuals reporting high perceived stress had hair cortisol levels 22% above those of low-stress controls 11.

Prolonged stress does not cause Cushing syndrome, but the downstream metabolic effects overlap. Weight gain concentrates in the abdomen. Sleep fragments. Blood pressure drifts upward. Fasting glucose creeps past normal thresholds. The difference: stress-related cortisol elevations tend to be modest and retain some diurnal rhythm, whereas true Cushing syndrome obliterates the midnight nadir.

"Patients with stress-related cortisol elevation still suppress on a 1 mg dexamethasone test," notes the Endocrine Society guideline, "which helps clinicians separate functional hypercortisolism from autonomous cortisol secretion" 8.

Interventions targeting the stress axis include cognitive behavioral therapy, structured exercise (150 minutes per week of moderate-intensity activity), and sleep optimization. A randomized trial of mindfulness-based stress reduction showed a significant decrease in salivary cortisol slope over 8 weeks compared to a waitlist control 12.

Pseudo-Cushing States: Look-Alikes That Mislead

Several common conditions raise cortisol enough to mimic biochemical Cushing syndrome on initial screening. These so-called pseudo-Cushing states include major depressive disorder, alcohol use disorder, poorly controlled type 2 diabetes, and morbid obesity 13.

Major depression activates the HPA axis through elevated CRH. Up to 50% of hospitalized patients with melancholic depression show non-suppression on the standard 1 mg dexamethasone suppression test 13. Alcohol use disorder can produce nearly identical biochemistry: elevated 24-hour urinary free cortisol, loss of diurnal rhythm, and mild cushingoid habitus. In both conditions, cortisol levels normalize once the underlying disorder is treated.

The CRH-dexamethasone test improves specificity. Patients receive 0.5 mg dexamethasone every 6 hours for 48 hours, followed by CRH stimulation. True Cushing patients show a cortisol rise above 1.4 mcg/dL, while pseudo-Cushing patients typically do not 14. This two-step protocol is particularly useful in diagnostically ambiguous cases.

How Elevated Cortisol Is Diagnosed

The Endocrine Society recommends at least two concordant first-line tests before pursuing imaging 8. The three validated first-line options each assess a different aspect of cortisol regulation.

24-hour urinary free cortisol (UFC) integrates total cortisol production over a full day. Values more than three times the upper limit of normal are highly specific for Cushing syndrome. Mild elevations (1 to 3 times normal) require confirmation because pseudo-Cushing states overlap in this range 8.

Late-night salivary cortisol exploits the fact that healthy individuals have very low cortisol near midnight. A value above the assay-specific cutoff on two separate collections has approximately 92 to 100% sensitivity and 93 to 100% specificity for Cushing syndrome in most studies 15.

1 mg overnight dexamethasone suppression test (DST) checks whether exogenous glucocorticoid suppresses morning cortisol below 1.8 mcg/dL. Failure to suppress suggests autonomous cortisol production. False positives occur with estrogen use (oral contraceptives raise cortisol-binding globulin), certain anticonvulsants that accelerate dexamethasone metabolism, and the pseudo-Cushing conditions discussed above 8.

Once biochemical hypercortisolism is confirmed, the next step is measuring plasma ACTH. Suppressed ACTH (below 5 pg/mL) points to an adrenal source. Normal or elevated ACTH prompts pituitary MRI and, if inconclusive, inferior petrosal sinus sampling 9.

Medications That Raise Cortisol Beyond Glucocorticoids

Oral contraceptives raise cortisol-binding globulin (CBG), increasing total serum cortisol without changing free (biologically active) cortisol. This artifact can make serum cortisol look elevated and can cause a false-positive DST result 16. Clinicians should use salivary cortisol or 24-hour UFC for screening in patients on estrogen-containing contraceptives.

Megestrol acetate, a synthetic progestin used as an appetite stimulant, has direct glucocorticoid receptor activity and can cause full-blown iatrogenic Cushing syndrome at high doses 17. Checkpoint inhibitors (nivolumab, pembrolizumab) occasionally cause hypophysitis, which can transiently raise cortisol before progressing to hypopituitarism. The adrenal effects of immune checkpoint therapy are reviewed in a 2018 Lancet Diabetes & Endocrinology series 18.

Sleep, Circadian Disruption, and Cortisol

Obstructive sleep apnea (OSA) is an underappreciated contributor. Intermittent hypoxia and sleep fragmentation activate the HPA axis. A meta-analysis of 22 studies found that patients with moderate-to-severe OSA had significantly higher evening cortisol compared to controls, and that CPAP therapy for 3 months partially normalized the cortisol rhythm 19.

Shift work produces similar circadian misalignment. Night-shift workers show flattened cortisol slopes (less difference between morning peak and evening trough), a pattern associated with higher BMI, insulin resistance, and cardiovascular risk in longitudinal cohort data 20. Targeted light-exposure timing and melatonin supplementation (0.5 to 3 mg before the desired sleep window) can partially re-entrain the circadian cortisol rhythm, though evidence for long-term metabolic benefit remains limited.

Treatment of Persistent Hypercortisolism

Treatment is cause-specific. This is not a condition where a single intervention fits all patients.

For Cushing disease (pituitary adenoma), first-line treatment is transsphenoidal surgery performed by an experienced neurosurgeon. Remission rates range from 65 to 90%, but recurrence occurs in 15 to 25% over 10 years 9. Second-line options include pituitary radiation, bilateral adrenalectomy, and medical therapy. Osilodrostat, a potent 11-beta-hydroxylase inhibitor, achieved normalization of urinary free cortisol in 53% of patients at 12 weeks in the LINC-3 trial (N=137) 21. Pasireotide (a somatostatin receptor ligand) normalized UFC in roughly 25% at 6 months in RESIST 22. Ketoconazole, metyrapone, and mifepristone (a glucocorticoid receptor antagonist approved for hyperglycemia in Cushing syndrome) are additional medical options covered by the 2021 Endocrine Society treatment guideline update.

For adrenal tumors, laparoscopic adrenalectomy is curative for benign adenomas. Adrenocortical carcinoma requires open resection and often adjuvant mitotane.

For ectopic ACTH, localization and resection of the source tumor is the goal. When the source cannot be found or resected, bilateral adrenalectomy may be necessary as a definitive measure, with lifelong glucocorticoid and mineralocorticoid replacement afterward.

For functional (stress-related) elevations, structured lifestyle interventions remain the primary recommendation. A Cochrane review of exercise interventions found that regular aerobic training reduced both self-reported stress and salivary cortisol reactivity to standardized stressors 23.

When to Seek Medical Evaluation

A single mildly elevated cortisol reading is not an emergency. The red flags that warrant prompt endocrinology referral include the combination of unexplained weight gain with proximal muscle weakness, wide purple striae, new-onset hypertension alongside hypokalemia, spontaneous bruising without anticoagulant use, and osteoporotic fractures in a patient under 50 8. Children showing weight gain with slowed linear growth should be evaluated urgently, as pediatric Cushing syndrome impairs final height if untreated.

Patients already on chronic glucocorticoids who develop cushingoid features should discuss dose reduction with their prescribing physician rather than discontinuing independently. A structured taper, sometimes guided by morning cortisol or cosyntropin stimulation testing, protects against adrenal crisis.